fda compounded semaglutide Novo asks to prevent compounders from making GLP-1 knockoffs The FDA Warns of the

Zoom out

This guidance applies to all GLP-1 medications, including semaglutide and tirzepatide, regardless of brand name

Kasuya et al

Additional Considerations Common side effects seen with Zepbound may include: Nausea or vomiting Diarrhea or constipation Abdominal pain Tiredness Zepbound may interact with Synthroid and increase the risk of medullary thyroid carcinoma (MTC)

Thus suggesting an additional action to that of the cardio-renal GLP-1- ANP axis

The combination may offer complementary benefits for PCOS including improved ovulatory function, better glycemic control, enhanced insulin sensitivity, and potential improvements in lipid profiles and androgen levels